 Connection
Jost Klawitter to Cannabidiol
This is a "connection" page, showing publications Jost Klawitter has written about Cannabidiol.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.922 |
|
|
|
-
Sempio C, Almaraz-Quinones N, Jackson M, Zhao W, Wang GS, Liu Y, Leehey M, Knupp K, Klawitter J, Christians U, Klawitter J. Simultaneous Quantification of 17 Cannabinoids by LC-MS-MS in Human Plasma. J Anal Toxicol. 2022 Apr 21; 46(4):383-392.
Score: 0.614
-
Gorbenko AA, Post TE, Strugala PK, Klaassen ES, Klumpers LE, de Visser SJ, Sempio C, Klawitter J, Heuberger JAAC, Groeneveld GJ. Low-dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug-drug interaction study. Br J Clin Pharmacol. 2026 Jun; 92(6):1595-1606.
Score: 0.198
-
Strickland JC, Tilton HE, Patton NM, Vandrey R, Austin Zamarripa C, Spindle TR, Lee DC, Bergeria CL, Wolinsky D, Klawitter J, Sempio C, Campos-Palomino J, Christians U, Feldner MT, Irons JG, Bonn-Miller MO. Effect of caffeine and cannabidiol (CBD) co-administration on ?9-tetrahydrocannabinol (?9-THC) subjective effects, performance impairment, and pharmacokinetics. Neuropsychopharmacology. 2025 Nov; 50(12):1827-1835.
Score: 0.194
-
Morris AWJ, Mueller RL, Sempio C, Klawitter J, Bryan AD, Bidwell LC, Hutchison KE. Effect of Cannabidiol and ?9-tetrahydrocannabinol on Anti-Inflammatory Lipid Mediator Synthesis in Humans. Cannabis Cannabinoid Res. 2025 08; 10(4):506-511.
Score: 0.191
-
Moore BF, Mueller NT, Perng W, Sauder KA, Hébert ET, Hoyt AT, Wymore EM, Boyle KE, Su EJ, Shapiro ALB, Kinney G, Sempio C, Klawitter J, Christians U, Dabelea D. Impact of prenatal exposure to delta 9-tetrahydrocannabinol and cannabidiol on birth size and postnatal growth trajectories. Pediatr Obes. 2025 Jan; 20(1):e13187.
Score: 0.184
-
Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA. Short-Term Cannabidiol with ?-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial. Mov Disord. 2024 May; 39(5):863-875.
Score: 0.175
-
Domen CH, Sillau S, Liu Y, Adkins M, Rajkovic S, Bainbridge J, Sempio C, Klawitter J, Leehey MA. Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and ?9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms. Mov Disord. 2023 07; 38(7):1341-1346.
Score: 0.165
-
Moore BF, Salmons KA, Hoyt AT, Swenson KS, Bates EA, Sauder KA, Shapiro ALB, Wilkening G, Kinney GL, Neophytou AM, Sempio C, Klawitter J, Christians U, Dabelea D. Associations between Prenatal and Postnatal Exposure to Cannabis with Cognition and Behavior at Age 5 Years: The Healthy Start Study. Int J Environ Res Public Health. 2023 03 10; 20(6).
Score: 0.163
-
Moore CF, Davis CM, Sempio C, Klawitter J, Christians U, Weerts EM. Effects of oral ?9-tetrahydrocannabinol and cannabidiol combinations on a sustained attention task in rats. Exp Clin Psychopharmacol. 2023 Oct; 31(5):881-887.
Score: 0.161
-
Gibson LP, Mueller RL, Winiger EA, Klawitter J, Sempio C, Williams S, Bryan AD, Bidwell LC, Hutchison KE. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products. Cannabis Cannabinoid Res. 2024 02; 9(1):320-334.
Score: 0.160
-
Peters EN, MacNair L, Mosesova I, Christians U, Sempio C, Klawitter J, Land MH, Ware MA, Turcotte C, Bonn-Miller MO. Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and ?9-tetrahydrocannabinol: a pilot study. Eur J Clin Pharmacol. 2022 Feb; 78(2):259-265.
Score: 0.148
-
Gibson LP, Karoly HC, Ellingson JM, Klawitter J, Sempio C, Squeri JE, Bryan AD, Bidwell LC, Hutchison KE. Effects of cannabidiol in cannabis flower: Implications for harm reduction. Addict Biol. 2022 01; 27(1):e13092.
Score: 0.147
-
Gibson LP, Gust CJ, Ellingson JM, YorkWilliams SL, Sempio C, Klawitter J, Bryan AD, Hutchison KE, Cinnamon Bidwell L. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use. Drug Alcohol Depend. 2021 06 01; 223:108718.
Score: 0.143
-
Gilman JM, Schmitt WA, Wheeler G, Schuster RM, Klawitter J, Sempio C, Evins AE. Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in Massachusetts. JAMA Netw Open. 2021 04 01; 4(4):e215490.
Score: 0.143
-
Wang GS, Bourne DWA, Klawitter J, Sempio C, Chapman K, Knupp K, Wempe MF, Borgelt L, Christians U, Leonard J, Heard K, Bajaj L. Disposition of Oral Cannabidiol-Rich Cannabis Extracts in Children with Epilepsy. Clin Pharmacokinet. 2020 08; 59(8):1005-1012.
Score: 0.136
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|